Posted by & filed under Growth & Valuation, Management Issues, Personal Finance.

Description: Vivek Ramaswamy got a pretty special present for his 32nd birthday in August: $1.1 billion in funding from SoftBank and other investors for the audacious biopharmaceutical firm he founded and leads, Roivant Sciences.


Date: Sep 21, 2017


Questions for discussion:

  • What is so unique about this financial structuring?
  • Why does it appeal to lenders?
  • How does it impact risk?

Leave a Reply

Your email address will not be published. Required fields are marked *